CART-Tech
Software for image processing and image guided cardiac interventions.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
N/A | - | ||
| Total Funding | 000k | ||
Related Content
CART-Tech B.V. is a medical technology company founded in 2014 by Paul Leufkens and Frebus van Slochteren, headquartered in Utrecht, Netherlands. The company operates in the electrophysiology market, developing a vendor-independent platform technology for augmented fluoroscopy to guide cardiac interventions. This market is projected to see significant growth, driven by an aging population and the increasing prevalence of cardiac arrhythmias.
The company's core product is the CARTBox, a system that enhances two-dimensional X-ray images by fusing them with pre-procedure 3D anatomical heart models created from MRI or CT scans. This technology functions like a 'GPS' for cardiologists, providing real-time, image-guided navigation during procedures. The platform is designed to improve the accuracy of lead placement in Cardiac Resynchronization Therapy (CRT) pacemaker implantations and to provide precise targeting for Ventricular Tachycardia (VT) ablations, aiming to improve patient outcomes and reduce procedural complexity.
CART-Tech's business model appears to be centered on the sale of its technology and forging strategic partnerships. In a significant recent development, CART-Tech entered into an exclusive development and commercialization agreement with BioCardia, Inc. for a product named Heart3D™ Fusion Imaging. Under this partnership, BioCardia has exclusive worldwide distribution rights for biotherapeutic delivery and for cardiac biopsy in the United States, while CART-Tech retains all other distribution rights. This collaboration leverages the intellectual property of both companies to advance cardiac fusion imaging, initially as a research tool and subsequently for standard clinical practice. The company has received funding from institutional investors, including Utrecht Holdings and DutchBasecamp.
Keywords: cardiac regenerative therapy, medical imaging software, electrophysiology, augmented fluoroscopy, cardiac interventions, Cardiac Resynchronization Therapy, CRT pacemakers, Ventricular Tachycardia ablation, image-guided therapy, medical device, Heart3D Fusion Imaging, cardiac mapping, real-time image fusion, 3D heart models, interventional cardiology, cardiovascular disease treatment, MedTech, Utrecht Holdings, BioCardia partnership, Paul Leufkens, Frebus van Slochteren